Literature DB >> 9608382

Dysafferentation: a novel term to describe the neuropathophysiological effects of joint complex dysfunction. A look at likely mechanisms of symptom generation.

D R Seaman1, J F Winterstein.   

Abstract

BACKGROUND AND OBJECTIVES: Since the founding of the chiropractic profession, very few efforts have been made to thoroughly explain the mechanism(s) by which joint complex dysfunction generates symptoms. Save for a few papers, only vague and physiologically inconsistent descriptions have been offered. The purpose of this article is to propose a precise and physiologically sound mechanism by which symptoms may be generated by joint complex dysfunction. DATA SOURCES: The data was accumulated over a period of years by reviewing contemporary articles and books, and subsequently retrieving relevant papers. Articles were also selected from volumes 1-4 of the Chiropractic Research Archives Collection. The Nexus, published by the David D. Palmer Health Sciences Library, and In Touch, published by Logan College of Chiropractic Library, were reviewed and relevant articles were retrieved. Medline searches were found to be ineffective because appropriate key indexing terms were difficult to identify. DATA SYNTHESIS: The symptoms generated by joint complex dysfunction, such as pain, nausea and vertigo, are probably caused by increased nociceptive input and/or reduced mechanoreceptive input.
CONCLUSIONS: Joint complex dysfunction should be included in the differential diagnosis of pain and visceral symptoms because joint complex dysfunction can often generate symptoms which are similar to those produced by true visceral disease.

Entities:  

Mesh:

Year:  1998        PMID: 9608382

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  12 in total

1.  Cervical curve restoration and forward head posture reduction for the treatment of mechanical thoracic pain using the pettibon corrective and rehabilitative procedures.

Authors:  Mark Morningstar
Journal:  J Chiropr Med       Date:  2002

2.  Craniocervical chiropractic procedures - a précis of upper cervical chiropractic.

Authors:  H Charles Woodfield; Craig York; Roderic P Rochester; Scott Bales; Mychal Beebe; Bryan Salminen; Jeffrey N Scholten
Journal:  J Can Chiropr Assoc       Date:  2015-06

3.  The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial.

Authors:  Ibrahim M Moustafa; Aliaa A Diab
Journal:  Rheumatol Int       Date:  2015-03-18       Impact factor: 2.631

4.  Spinal manipulation and anterior headweighting for the correction of forward head posture and cervical hypolordosis: A pilot study.

Authors:  Mark W Morningstar; Megan N Strauchman; Darin A Weeks
Journal:  J Chiropr Med       Date:  2003

5.  Strength gains through lumbar lordosis restoration.

Authors:  Mark W Morningstar
Journal:  J Chiropr Med       Date:  2003

6.  Adolescent idiopathic scoliosis treatment using pettibon corrective procedures: a case report.

Authors:  Mark W Morningstar; Megan N Strauchman; Greg Gilmour
Journal:  J Chiropr Med       Date:  2004

7.  Cervical hyperlordosis, forward head posture, and lumbar kyphosis correction: A novel treatment for mid-thoracic pain.

Authors:  Mark W Morningstar
Journal:  J Chiropr Med       Date:  2003

8.  The Chiropractic Vertebral Subluxation Part 10: Integrative and Critical Literature From 1996 and 1997.

Authors:  Simon A Senzon
Journal:  J Chiropr Humanit       Date:  2019-04-06

9.  Reflex control of the spine and posture: a review of the literature from a chiropractic perspective.

Authors:  Mark W Morningstar; Burl R Pettibon; Heidi Schlappi; Mark Schlappi; Trevor V Ireland
Journal:  Chiropr Osteopat       Date:  2005-08-09

10.  Scoliosis treatment using a combination of manipulative and rehabilitative therapy: a retrospective case series.

Authors:  Mark W Morningstar; Dennis Woggon; Gary Lawrence
Journal:  BMC Musculoskelet Disord       Date:  2004-09-14       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.